Sen. Wellstone developing FDA reform bill on Class III device issues.
This article was originally published in The Gray Sheet
Executive Summary
SEN. WELLSTONE FDA REFORM BILL ON CLASS III DEVICE ISSUES is expected to be introduced in the next few weeks. Staffers for the Minnesota Democrat have been meeting with representatives of a coalition of Class III device manufacturers, including Minnesota-based companies Medtronic and St. Jude, and the bill is expected to include elements of an FDA reform package circulated earlier this year by the group ("The Gray Sheet" June 12, p. 11).
You may also be interested in...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.